scholarly journals Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements

2020 ◽  
Vol 38 (5) ◽  
pp. 485-497 ◽  
Author(s):  
Pierre Johansen ◽  
Daniel Howard ◽  
Ryan Bishop ◽  
Søren Ilsøe Moreno ◽  
Kristine Buchholtz
2013 ◽  
Vol 16 (7) ◽  
pp. A591 ◽  
Author(s):  
M. Charokopou ◽  
F.J. Sabater ◽  
R. Townsend ◽  
M. Roudaut ◽  
B.G. Verheggen

2016 ◽  
Vol 61 (3) ◽  
pp. 289-298 ◽  
Author(s):  
Hazel Squires ◽  
James Chilcott ◽  
Ronald Akehurst ◽  
Jennifer Burr ◽  
Michael P. Kelly

2019 ◽  
Vol 20 (2) ◽  
pp. 207-219
Author(s):  
Samron Brhane Gebregergish ◽  
Mahmoud Hashim ◽  
Bart Heeg ◽  
Thomas Wilke ◽  
Marco Rauland ◽  
...  

2021 ◽  
Vol 24 ◽  
pp. S45
Author(s):  
B. Németh ◽  
M. Choon-Quinones ◽  
M.O. Tóth ◽  
X.Y. Jia ◽  
T. Zelei ◽  
...  

2012 ◽  
Vol 17 (1) ◽  
pp. 44-52 ◽  
Author(s):  
Rikke SØGaard ◽  
Jes Lindholt

Objective To investigate whether the credibility of health economic models of screening for abdominal aortic aneurysms for health policy decisionmaking has improved since 2005 when a systematic review by Campbell et al. concluded that reporting standards were poor and there was divergence between the findings of studies that was hard to explain. Methods A systematic literature review was carried out following PRISMA reporting principles. Health economic models of the cost-effectiveness of screening for abdominal aortic aneurysms published between 2005-2010 were included. Key characteristics were extracted and the models were assessed for quality against guidelines for best practice by a multidisciplinary team. Results Seven models were identified and found to provide divergent guidance. Only three reports met 10 of the 15 quality criteria. Conclusions Researchers in the field seem to have benefited from general advances in health economic modelling and some improvements in reporting were noted. However, the low level of agreement between studies in model structures and assumptions, and difficulty in justifying these (convergent validity), remain a threat to the credibility of health economic models. Decision-makers should not accept the results of a modelling study if the methods are not fully transparent and justified. Modellers should, whenever relevant, supplement a primary report of results with a technical report detailing and discussing the methodological choices made.


2021 ◽  
Author(s):  
Lesong Conteh ◽  
Kathryn Shuford ◽  
Efundem Agboraw ◽  
Mara Kont ◽  
Jan Kolaczinski ◽  
...  

2020 ◽  
Vol 23 ◽  
pp. S595
Author(s):  
X. Lu ◽  
M. Radford ◽  
M. Gharaibeh ◽  
P. Gabb ◽  
A. Hewins ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document